Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD?

被引：0
|
作者：
Meinrad Gawaz
机构：
[1] Eberhard-Karls University of Tübingen,professor and Director of the Department of Medicine
来源：
Nature Clinical Practice Cardiovascular Medicine | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：648 / 649
页数：1
相关论文
共 50 条
  • [1] Does prasugrel achieve superior platelet inhibition when compared with clopidogrel in patients with CAD?
    Gawaz, Meinrad
    NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE, 2006, 3 (12): : 648 - 649
  • [2] Impact of chronic kidney disease on platelet inhibition of clopidogrel and prasugrel in Japanese patients
    Nishi, Takeshi
    Ariyoshi, Noritaka
    Nakayama, Takashi
    Fujimoto, Yoshihide
    Sugimoto, Kazumasa
    Wakabayashi, Shinichi
    Hanaoka, Hideki
    Kobayashi, Yoshio
    JOURNAL OF CARDIOLOGY, 2017, 69 (5-6) : 752 - 755
  • [3] Impact of Switching Prasugrel to Clopidogrel on Platelet Inhibition and Clinical Outcomes
    Kerneis, Mathieu
    Abtan, Jeremie
    Connor, Stephen A. O.
    Martin, Rejane
    Cayla, Guillaume
    Barthelemy, Olivier
    Vignalou, Jean-Baptiste
    Beygui, Farzin
    Brugier, Delphine
    Silvain, Johanne
    Collet, Jean-Philippe
    Montalescot, Gilles
    CIRCULATION, 2012, 126 (21)
  • [4] Platelet inhibition with prasugrel (CS-747) compared with clopidogrel in patients undergoing coronary stenting: the subset from the JUMBO study
    Serebruany, V. L.
    Midei, M. G.
    Meilman, H.
    Malinin, A. I.
    Lowry, D. R.
    POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (968) : 404 - 410
  • [5] On-Treatment Platelet Reactivity Through Hemodialysis Compared with Prasugrel and Clopidogrel in Chronic Hemodialysis Patients
    Kamada, Taro
    Iwasaki, Masamichi
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (16) : S57 - S58
  • [6] Increased active metabolite formation explains the greater platelet inhibition with prasugrel compared to high-dose clopidogrel
    Payne, Christopher D.
    Li, Ying Grace
    Small, David S.
    Ernest, C. Steven, II
    Farid, Nagy A.
    Jakubowski, Joseph A.
    Brandt, John T.
    Salazar, Daniel E.
    Winters, Kenneth J.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 555 - 562
  • [7] Inhibition Of Platelet Aggregation With Prasugrel And Clopidogrel: An Integrated Analysis In 750 Subjects
    Li, Grace Y.
    Ni, Lan
    Brandt, John T.
    Small, David S.
    Payne, Christopher D.
    Ernest, C. Steven
    Rohatagi, Shashank
    Farid, Nagy A.
    Jakubowski, Joseph A.
    Winters, Kenneth J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 76I - 76I
  • [8] Platelet inhibition with prasugrel (CS-747) versus clopidogrel: the JUMBO platelet substudy
    Serebruany, V. L.
    Midei, M. G.
    Meilmann, H.
    Malinin, A. I.
    Lowry, D. L.
    EUROPEAN HEART JOURNAL, 2006, 27 : 865 - 865
  • [9] Enhanced active metabolite generation and platelet inhibition with prasugrel compared to clopidogrel regardless of genotype in thienopyridine metabolic pathways
    Braun, Oscar O.
    Angiolillo, Dominick J.
    Ferreiro, Jose L.
    Jakubowski, Joseph A.
    Winters, Kenneth J.
    Effron, Mark B.
    Duvvuru, Suman
    Costigan, Timothy M.
    Sundseth, Scott S.
    Walker, Joseph R.
    Saucedo, Jorge F.
    Kleiman, Neal S.
    Varenhorst, Christoph
    THROMBOSIS AND HAEMOSTASIS, 2013, 110 (06) : 1223 - 1231
  • [10] Switching patients with high-on treatment platelet inhibition from prasugrel to clopidogrel after an acs exposes to clopidogrel resistance
    Kerneis, M.
    Abtan, J.
    Silvain, J.
    Cayla, G.
    Connor, S. O.
    Barthelemy, O.
    Beygui, F.
    Collet, J. P.
    Brugier, D.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2012, 33 : 316 - 316
12345